Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-16
2007-01-16
Lambkin, Deborah C. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S561000, C514S569000, C514S532000, C514S646000, C548S417000, C560S008000, C562S405000, C564S305000
Reexamination Certificate
active
10960449
ABSTRACT:
This patent discloses a substituted fullerenes, compositions comprising the same, and their use as antioxidants. The substituted fullerenes comprise a fullerene core (Cn) and at least one of: (i) from 1 to 6 (>CX1X2) groups bonded to the fullerene core; (ii) from 1 to 18 —X3groups bonded to the fullerene core; (iii) from 1 to 6 —X4— groups bonded to the fullerene core; or (iv) from 1 to 6 dendrons bonded to the fullerene core.
REFERENCES:
patent: 5648523 (1997-07-01), Chiang
patent: 5739376 (1998-04-01), Bingel
patent: 5811460 (1998-09-01), Friedman et al.
patent: 5972993 (1999-10-01), Ptchelintsev
patent: 5994410 (1999-11-01), Chiang et al.
patent: 6162926 (2000-12-01), Murphy et al.
patent: 6204391 (2001-03-01), Friedman et al.
patent: 6265443 (2001-07-01), Choi et al.
patent: 6380434 (2002-04-01), Chiang
patent: 6399785 (2002-06-01), Murphy et al.
patent: 6448412 (2002-09-01), Murphy et al.
patent: 6452037 (2002-09-01), Chiang
patent: 6506928 (2003-01-01), Hirsch
patent: 6538153 (2003-03-01), Hirsch et al.
patent: 6765098 (2004-07-01), Nakamura et al.
patent: 6777445 (2004-08-01), Lei et al.
patent: 6790963 (2004-09-01), Chiang et al.
patent: 6890676 (2005-05-01), Nuber et al.
patent: 6949660 (2005-09-01), Chiang et al.
patent: 7008713 (2006-03-01), Nuber et al.
patent: 7018599 (2006-03-01), Nakamura et al.
patent: 7071406 (2006-07-01), Smalley et al.
patent: 2002/0098180 (2002-07-01), Lei et al.
patent: 2003/0027870 (2003-02-01), Wilson et al.
patent: 2003/0162837 (2003-08-01), Dugan et al.
patent: 2003/0180491 (2003-09-01), Hirsch et al.
patent: WO99/43358 (1999-09-01), None
patent: WO00/44357 (2000-08-01), None
Dugan et al.,Parkinsonism and Related Disorders7:243-246 (2001).
Dugan et al.,Neurobiology of Disease3:129-135 (1996).
Dugan et al.,Proc. Natl. Acad. Sci. USA94:9434-9439 (Aug. 1997).
Gharbi et al.,ECS Proceedings(May 14-19, 2000).
Wilson, “Biological Aspects of Fullerenes,” Chapter 10,Fullerenes: Chemistry, Physics and Technology, K. Kadish and R. Ruoff eds., 2000 John Wiley & Sons NY, NY.
Chiang et al.,J. Chem. Soc., Chem. Commun., pp. 1283-1284 (1995).
Fumelli et al.,The Journal of Investigative Dermatology115:835-841 (Nov. 2000).
Straface et al.,FEBS Letters454:335-340 (1999).
Lotharius e al.,The Journal of Neuroscience19(4):1284-1293 (Feb. 15, 1999).
Lin et al.,Journal of Neurochemistry72(4):1634-1640 (1999).
Lin et al.,Neuroscience Research43:317-321 (2002).
Monti et al.,Biomedical and Biophysical Research Communications277:711-717 (2000).
Tsao et al.,Journal of Antimicrobial Chemotherapy49:641-649 (2002).
Huang et al.,Eur. J. Biochem. 254:38-43 (1998).
Hu Yi-Zhen
Lebovitz Russ
Wilson Stephen R.
Zhu Tong
C Sixty Inc.
Lambkin Deborah C.
Williams Morgan & Amerson P.C.
LandOfFree
Substituted fullerene compositions and their use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted fullerene compositions and their use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted fullerene compositions and their use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3780872